 |
|
Hemorrhage vs Rethrombosis After Thrombolysis for Acute Myocardial Infarction
Gerald C. Timmis, MD;
Eberhard F. Mammen, MD;
Renato G. Ramos, MD;
Seymour Gordon, MD;
V. Gangadharan, MD;
Andrew M. Hauser, MD;
Douglas C. Westveer, MD;
James R. Stewart, MD
Arch Intern Med. 1986;146(4):667-672.
Abstract
• To determine whether or not the timing of heparin infusion affects either bleeding or reocclusion following intracoronary streptokinase for acute myocardial infarction, heparin was infused immediately after streptokinase in 89 patients and was delayed for 12 hours in the subsequent 93. Bleeding occurred in 22 immediate-heparin patients and was major in five (one fatal); there were 14 hemorrhages in the delayed-heparin group, all minor. At discharge, reocclusions were observed in 18% (12/68) of immediate-heparin patients, and 11% (3/27) of the latter. Bioassayed fibrinogen levels displayed sustained depression regardless of bleeding for 20 hours after streptokinase; however, defibrinogenation measured by immunoassay was much less striking. This suggests that high levels of fibrinogen degradation products spuriously affect the bioassay of fibrinogen. We conclude that bleeding is related to the anticoagulant effects of fibrinogen degradation products interacting with heparin, and may be largely independent of hypofibrinogenemia. Delaying heparin for 12 hours may decrease the risk of bleeding while little affecting the risk of reocclusion.
(Arch Intern Med 1986;146:667-672)
Author Affiliations
From the Division of Cardiovascular Diseases, William Beaumont Hospital, Royal Oak, Mich (Drs Timmis, Ramos, Gordon, Gangadharan, Westveer, Hauser, and Stewart); and the Department of Surgery, School of Medicine, Wayne State University, Detroit (Dr Mammen).
Footnotes
Accepted for publication July 26, 1985.
Reprint requests to Division of Cardiovascular Diseases, William Beaumont Hospital, 3601 W 13 Mile Rd, Royal Oak, MI 48072 (Dr Timmis).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Outcome of Patients with Acute Myocardial Infarction Who Are Ineligible for Thrombolytic Therapy
Cragg et al.
ANN INTERN MED 1991;115:173-177.
ABSTRACT
Nonemergent Cardiac Catheterization and Risk-Stratified Revascularization Following Thrombolytic Therapy for Acute Myocardial Infarction: A Critical Analysis of Therapy in the Community Setting
Rowe et al.
Arch Intern Med 1989;149:1611-1617.
ABSTRACT
Overview of Results of Randomized Clinical Trials in Heart Disease: I. Treatments Following Myocardial Infarction
Yusuf et al.
JAMA 1988;260:2088-2093.
ABSTRACT
|
